Binder against programmed death-ligand and application thereof
US12338284B2 · kind B2 · utility
0Cited by
1References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 10, 2020 |
| Grant date | Jun 24, 2025 |
| Priority date | — |
| Expiry date | Dec 6, 2042 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Provided is an anti-PD-L1 monoclonal antibody. The antibody can be used to prepare a drug for preventing or treating a disease related to PD-L1.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.